Identifying Haemoglobinopathy Carriers in Portugal: Challenges and Considerations from a Primary Health Care Perspective

Authors

  • Marta Rainho Medicina Geral e Familiar. Unidade de Saúde Familiar Luísa Todi. Unidade Local de Saúde da Arrábida. Setúbal.
  • Elisa Melo Ferreira Medicina Geral e Familiar. Unidade de Saúde Familiar Luísa Todi. Unidade Local de Saúde da Arrábida. Setúbal.

DOI:

https://doi.org/10.20344/amp.20812

Keywords:

Hemoglobinopathies/diagnosis, Portugal, Primary Health Care

Abstract

N/a.

Downloads

Download data is not yet available.

References

Santos D, Barreto M, Kislaya I, Mendonça J, Machado MP, Lopes P, et al. Prevalence rate of thalassemia carriers among individuals with microcytosis or hypochromia in Portugal. Acta Med Port. 2023;36:467-74. DOI: https://doi.org/10.20344/amp.19162

Martinez PA, Angastiniotis M, Eleftheriou A, Gulbis B, Pereira MM, Petrova-Benedicts R, et al. Haemoglobinopathies in Europe: health & migration policy perspectives. Orphanet J Rare Dis. 2014;9:97. DOI: https://doi.org/10.1186/1750-1172-9-97

World Health Organization. Executive Board, 118th Session. Thalassaemia and other haemoglobinopathies: document EB118/5. Geneva: WHO; 2006.

van Vliet ME, Kerkhoffs JL, Hartevel CL, Houwink EJ. Hemoglobinopathy prevention in primary care: a reflection of underdetection and difficulties with accessibility of medical care, a quantitative study. Eur J Hum Genet. 2022;30:790-4. DOI: https://doi.org/10.1038/s41431-022-01051-8

Cataldo F. Immigration and changes in the epidemiology of hemoglobin disorders in Italy: an emerging public health burden. Ital J Ped. 2012;38:32. DOI: https://doi.org/10.1186/1824-7288-38-32

Direção-Geral da Saúde. Prevenção das formas graves de hemoglobinopatia: Circular Normativa n.º 18/DSMIA, de 07/09/2004. Lisboa: DGS; 2004.

Lopes SM, Machado R. Relatório de imigração, fronteiras e asilo 2022. Lisboa: Serviço de Estrangeiros e Fronteiras; 2023.

Costa SM, Sobral M, Delgadinho G. Hemoglobinopatias em Portugal e a intervenção do médico de família. Rev Por Med Ger Fam. 2016;32:416-24. DOI: https://doi.org/10.32385/rpmgf.v32i6.11963

Instituto Nacional de Saúde Doutor Ricardo Jorge. Rastreio Neonatal: 83.436 recém-nascidos estudados em 2022. [consultado 2023 nov 12]. Disponível em: https://www.insa.min-saude.pt/rastreio-neonatal-83-436-recem-nascidos-estudados-em-2022/.

Lobitz S, Telfer P, Cela E, Allaf B, Angastiniotis M, Johansson CB, et al. Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference. Br J Haematol. 2018;183:648-60. DOI: https://doi.org/10.1111/bjh.15600

Published

2024-02-19

How to Cite

1.
Rainho M, Melo Ferreira E. Identifying Haemoglobinopathy Carriers in Portugal: Challenges and Considerations from a Primary Health Care Perspective. Acta Med Port [Internet]. 2024 Feb. 19 [cited 2024 Apr. 23];37(3):235-6. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/20812

Issue

Section

Letters to the Editor